These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 999253)

  • 41. [Comparison of the effect of trypsin and chymotrypsin on the pharmacokinetics of penicillins in the body of rats].
    Geĭtman IIa; Butylina LV; Kivman GIa
    Antibiotiki; 1975 Nov; 20(11):1019-23. PubMed ID: 1225167
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolism and disposition of diethylene glycol in rat and dog.
    Mathews JM; Parker MK; Matthews HB
    Drug Metab Dispos; 1991; 19(6):1066-70. PubMed ID: 1687012
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 1st communication: absorption, pharmacokinetics and excretion in rats and dogs.
    Yamada Y; Endo M; Kohno M; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):457-65. PubMed ID: 1642668
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs.
    Halpin RA; Geer LA; Zhang KE; Marks TM; Dean DC; Jones AN; Melillo D; Doss G; Vyas KP
    Drug Metab Dispos; 2000 Oct; 28(10):1244-54. PubMed ID: 10997947
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics of norfloxacin in dogs after single intravenous and single and multiple oral administrations of the drug.
    Brown SA; Cooper J; Gauze JJ; Greco DS; Weise DW; Buck JM
    Am J Vet Res; 1990 Jul; 51(7):1065-70. PubMed ID: 2389884
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rifampin in the horse: comparison of intravenous, intramuscular, and oral administrations.
    Burrows GE; MacAllister CG; Beckstrom DA; Nick JT
    Am J Vet Res; 1985 Feb; 46(2):442-6. PubMed ID: 3994110
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Experimental study of a new method of endolymphatic antibiotic administration and a trial of its clinical use].
    Shcherbakova EG; Vyrenkov IuE; Panchenkov RT; Iarema IV; Myl'nikov AV
    Antibiotiki; 1980 May; 25(5):375-81. PubMed ID: 6992708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rifampicin as an oral angiogenesis inhibitor targeting hepatic cancers.
    Shichiri M; Fukai N; Kono Y; Tanaka Y
    Cancer Res; 2009 Jun; 69(11):4760-8. PubMed ID: 19458074
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
    Bialer M; Wu WH; Look ZM; Silber BM; Yacobi A
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Rifampicin action on the ultrastructure of E. coli cells].
    Zhukov VG; Navashin SM; Zaslavskaia PL
    Antibiotiki; 1978 Feb; 23(2):168-71. PubMed ID: 343711
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics of orally administered DL-α-lipoic acid in dogs.
    Zicker SC; Avila A; Joshi DK; Gross KL
    Am J Vet Res; 2010 Nov; 71(11):1377-83. PubMed ID: 21034330
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Mechanism of the effect of proteolytic enzymes on antibiotic pharmacokinetics].
    Geĭtman IIa; Kardash BE
    Antibiotiki; 1979 Dec; 24(12):922-8. PubMed ID: 518051
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetic study of intravenous rifampicin.
    Nitti V; Virgilio R; Patricolo MR; Iuliano A
    Chemotherapy; 1977; 23(1):1-6. PubMed ID: 832508
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Liver function tests in rats treated with oral rifampicin during extended periods].
    Rodriguez Garay EA; Spetale M; De Robledo HA; Morisoli LS; Rassero J
    Farmaco Prat; 1972 Nov; 27(11):633-42. PubMed ID: 4645265
    [No Abstract]   [Full Text] [Related]  

  • 55. [Characteristics of pharmacokinetics of liposome-incorporated rifampicin in rats after intratracheal administration].
    Gurevich GL; Berezovskaia LN; Manuĭlov KK
    Antibiot Khimioter; 1992 Jul; 37(7):25-8. PubMed ID: 1456804
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pharmacokinetics of amphoglucamine in an experiment].
    Fateeva LI
    Antibiot Med Biotekhnol; 1986 Apr; 31(4):280-3. PubMed ID: 3717925
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Comparative effectiveness of rifampicin for parenteral administration and internal dose in the treatment of experimental plague in albino mice].
    Makarovskaia LN; Ryzhkova VV; Zurabian VA; Bugaeva OK; Pasiukov VV; Fomina IP; Navashin SM
    Antibiot Khimioter; 1995 Jun; 40(6):37-9. PubMed ID: 8593093
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rifampicin (600 mg) kinetics in the undernourished.
    Polasa K; Krishnaswamy K
    Indian J Med Res; 1986 Feb; 83():175-8. PubMed ID: 3710544
    [No Abstract]   [Full Text] [Related]  

  • 59. Influence of the enzyme induction by rifampicin on its presystemic metabolism.
    Loos U; Musch E; Jensen JC; Schwabe HK; Eichelbaum M
    Pharmacol Ther; 1987; 33(1):201-4. PubMed ID: 3628475
    [No Abstract]   [Full Text] [Related]  

  • 60. Metabolism and pharmacokinetics of the antibiotic rifampin.
    Kenny MT; Strates B
    Drug Metab Rev; 1981; 12(1):159-218. PubMed ID: 7028436
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.